Semaglutide for Weight Loss: What Patients Should Know

Semaglutide is a GLP-1 receptor agonist — a class of medications originally developed for type 2 diabetes that is also FDA-approved for chronic weight management in eligible adults under brand names such as Wegovy®.

How it works (high level): GLP-1 medications mimic a hormone that helps regulate appetite and food intake. They can slow stomach emptying and reduce hunger signals — supporting calorie reduction when combined with lifestyle changes.

Who may be considered: Eligibility depends on BMI, health history, current medications, and clinical guidelines. Not everyone qualifies — a medical provider evaluates whether benefits outweigh risks for your situation.

Medical evaluation: Expect a review of medical history, current medications, prior weight-loss attempts, and relevant labs when appropriate. NeuMed providers discuss whether semaglutide, another GLP-1 option, or a non-medication approach fits best.

Common side effects: Nausea, vomiting, diarrhea, constipation, and abdominal discomfort are reported — often most noticeable when starting or increasing dose. Most side effects are manageable; severe or persistent symptoms need prompt follow-up.

Monitoring and follow-up: Dosing is typically started low and increased gradually. Regular check-ins help manage side effects, track progress, and adjust the plan. Individual response varies — no specific outcome can be guaranteed.

Lifestyle component: Medication works best alongside nutrition guidance, physical activity, sleep, and behavioral support. Medical weight loss at NeuMed emphasizes sustainable habits, not medication alone.

Why clinician supervision matters: GLP-1 medications require prescription and monitoring. Self-sourcing or using medications without evaluation carries significant safety risks.

Ready to learn more? Schedule a medical weight loss consultation at NeuMed Houston. See our Medical Weight Loss program and pricing page for current options.